云南省11个民族腺苷脱氨酶(ADA)频率的分布调查

采用电泳技术对云南省汉、彝、自、傣、哈尼、瑶、布朗、基诺、拉祜、佤及苦聪等11个民族的ADA 进行了表型分布调查。并对-20℃、4℃、室温(20℃左右)保存的血痕ADA 活性进行了测定。在汉族人群中发现了一例ADA4-1稀有型,家系调查表明其是由父亲遗传下来的。     

Republicans in the South

This article explains the failure of the Republican party to reproduce their dominance of the South in presidential elections at lower electoral levels. First, the foreign policy and social issues that have benefitted Republican presidential candidates have lower salience in state and congressional elections. Second, sustained Republican control of the White House has exposed the party to recurrent mid-term setbacks at lower electoral levels. Third, deficiencies of local party organization and a paucity of identifiers deprives the Republicans of candidates in sufficient quantity and quality to be competitive with Democrats.     

过敏性休克死亡机体内白三烯变化的研究

本研究采用反相洗脱高效液相色谱(HPLC)法检测青霉素和血清过敏休克致死机体中自三烯(Leukotrienes,LTs)。(1)过敏休克前血中未检出LTs的任一组分,休克死亡后检出LTB_4和LTD_4。青霉素过敏血中LTB_4含量是10.10±4.76(ng/ml),LTD_4是26.75±6.55(ng/ml),未检出LTC_4和LTF_4。(2)正常动物肺,脾和肾中均未检出LTs。过敏休克的肺,脾和肾中不仅检出LTB_4和LTD_4,而且在不同脏器中呈规律分布。青霉素过敏肺中LTs_4是23.75±3.80(ng/g),LTD4是58.58±11.39(ng/g))未检出LTC_4和LTE_4。脾中仅有LTB_424.36±3.62(ng/g)。肾中仅有LTD_12.17±2.55(ng/g)。(3)过敏休克致死机体置室温6或12h,或置冰箱48h再测LTs,未见明显变化。(4)青霉素和血清诱发的过敏休克中,LTs的增加和分布是一致的。本研究提示:LTs含量和分布的变化是过敏性休克所共有,可为过敏性休克急死的法医学死因检定提供有价值的证据。     

检测体液中氰含量的荧光光度法研究

本文报道了应用取代反应检测体液中氰含量的荧光光度法。探讨了检测的具体方法和有关条件对检测的影响。检测了正常人血、尿液和唾液中氰含量,并检测了小鼠氰化物染毒死亡后血中氰含量。研究表明,本法不但可检测体液中致死量的氰化物含量,亦可检测体液中正常氰含量。     

Programme and performance budgeting in Malaysia

This paper reviews the evolution of programme and performance budgeting (PPB) in Malaysia from its beginning in 1969, through the in-depth implementation phase which began in 1972, to the present day. It outlines the system in the Ministry of Health, where PPB has been extensively developed and comments on the systems established in other in-depth ministries, in several of which little appears to have been achieved. In 1981 all other agencies were asked to adopt PPB in their budget submissions. Compliance has been superficial. The paper explores the constraints to the further development of PPB. These range from difficulties of securing appropriate staff, lack of top-level commitment and information problems, to the inherent difficulties of programming and performance measurement. In seeking to evaluate the success of PPB the paper adopts two approaches. The first, involving a small questionnaire survey amongst those involved in PPB, reveals rather guarded opinions concerning its usefulness and progress. The second, which explores the use made of PPB, reveals little use by legislators, budget officers or line managers, and no link between PPB and the planning process. However the audit department expresses considerable interest in relation to performance auditing. In summary the achievements of PPB have been modest.     

用Y—染色体特异DNA探针鉴识微量干血痕性别的研究

法医鉴识干血痕性别,通常是用盐酸阿地平染色观察 Y—小体的方法。重组 DNA 技术的发展与应用,为法医物证检验开辟了新的领域。本文用 Y—染色体特异 DNA 探针鉴识干血痕性别的成功,为法医的血痕性别签定,提供了一种新的检验方法。     

应用判别分析法判断胸骨性别的研究

本文测量了85例国人胸骨(男52,女33)的全长、柄长、体长、柄最大宽、体最大宽、柄最大厚及体最大厚七个项目,发现所有项目都具有非常显著的性别差异,但两性间重迭率较高,用单项难以准确判定性别。为此,采用 Fisher 判别分析法建立了判定胸骨性别的判别函数,判别率最高达90%。考虑到残缺胸骨的性别鉴定,亦建立了相应的判别函数。与国外研究相比,本文方法判别率较高且更具有实用价值。     

Sudden death in an infant resulting from torsion of the uterine adnexa

A 2-month-old infant girl died suddenly as a result of torsion of the uterine adnexa. The infant was found unresponsive in bed and was pronounced dead shortly after her arrival at a hospital. There were no antecedent signs of illness. At autopsy, the right ovary and right fallopian tube were twisted and were dark purple, swollen, and necrotic. The right ovary was enlarged by a follicle cyst 4 cm in diameter, which likely precipitated the torsion. The mechanism of death was unclear but may have resulted from the release of cytokines produced in response to necrotic adnexal tissue. Fatal uterine adnexal torsion has been reported rarely in infants; in all those cases there were antecedent symptoms. Torsion of the uterine adnexa should be included in the differential diagnosis of sudden death in infancy.     

Medical devices: reclassification and codification of the absorbable polydioxanone surgical suture. Final rule

The Food and Drug Administration (FDA) is announcing that it has issued an order in the form of a letter to Ethicon, Inc., reclassifying the absorbable polydioxanone surgical (PDS) suture intended for use in soft tissue approximation, including use in pediatric cardiovascular tissue where growth is expected to occur and ophthalmic surgery, from class III (premarket approval) to class II (special controls). Elsewhere in this issue of the Federal Register, FDA is announcing the availability of the guidance document entitled "Class II Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA," which is immediately in effect as the special control for the PDS suture, but remains subject to public comment and possible future revision under the agency's good guidance practices. The agency is reclassifying this device into class II because new information supplied by the petitioner indicates that special controls, in addition to general controls, will provide reasonable assurance of the safety and effectiveness of the device, and there is sufficient information to establish special controls. Accordingly, the order is being codified in the Code of Federal Regulations. Any firm submitting a premarket notification (510(k)) for a new PDS suture will need to address the issues covered in the special control guidance. However, the firm need only show that its device meets the recommendations of the guidance or in some other way provides equivalent assurances of safety and effectiveness.